DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Oncolytic Virus Therapy Market & Pipeline Outlook 2022" report to their offering.
Global Oncolytic Virus Therapy Market & Pipeline Outlook 2022 report analyzes ongoing clinical and non-clinical trends in the oncolytic virus therapy market.
Currently there are 2 oncolytic virus therapies commercially available in the market. This report analyzes the ongoing clinical trial of 48 oncolytic virus therapies in clinical pipeline and gives comprehensive clinical insight on various parameters associated with the development of the oncolytic virus therapies. Most of the oncolytic virus therapy in clinical trials are in preclinical phase followed by Phase-I trials.
The preceding decades have shown the higher incidence and prevalence trends for the cancer. Globally, the scenario is worsening with the mounting number of cancer patients every year. Thousands of regimens have been employed for the eradication of this deadly disease and yet the new interventions are anticipated. Undeniably, several modalities have resulted in some form of relief so far, but the triumph towards cancer abolition is long way road.
The major role of developing the new therapy for the treatment of cancer is to have broader therapeutic index which represents the high potency towards the malignant cells with low or no toxicities towards healthy cells. One such approach is the use of the viruses for the treatment of cancer turning into term known as viral oncotherapy. With the advances in oncology and the virology, the routes towards the engineering of viruses with increased tumor selectivity and enhanced oncolytic activity is conceivable.
Key Topics Covered:
1. Prologue to Oncolytic Virus
2. Primer of Virotherapy in Malignancies
3. Mechanism Involved in Viral Oncolysis
4. Cancer Immunotherapy by Oncolytic Viruses
5. Varieties of Viruses Casted as Oncolytic Viruses
6. Approved Oncolytic Virus Therapeutics
7. Potential Oncolytic Viruses for Cancers
8. Global Oncolytic Virus Therapy Market Overview
9. Oncolytic Virus Market Dynamics
10. Future Aspects of Oncolytic Viral Therapy
11. Global Oncolytic Virus Clinical Pipeline by Company, Indication & Phase
12. Marketed Oncolytic Virus Clinical Insight by Company & Indication
13. No Development Reported Oncolytic Virus Clinical Insight by Company, Indication & Phase
14. Competitive Landscape
- BioVex
- Cell Genesys
- Crusade Laboratories
- Genelux Corporation
- Jennerex Biotherapeutics
- Lokon Pharma
- Merck
- MultiVir
- Oncolys BioPharma
- Oncolytics Biotech
- Oncos Therapeutics
- PsiOxus Therapeutics
- Shanghai Sunway Bioteh
- Takara Bio
- VCN Biosciences
- ViroTarg
- Vyriad
For more information about this report visit http://www.researchandmarkets.com/research/xwb8k7/global_oncolytic
